Emily English - 30 Dec 2025 Form 4 Insider Report for Cartesian Therapeutics, Inc. (RNAC)

Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Emily English
Issuer symbol
RNAC
Transactions as of
30 Dec 2025
Net transactions value
+$24,750
Form type
4
Filing time
02 Jan 2026, 16:03:30 UTC
Previous filing
02 Dec 2025
Next filing
06 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
English Emily Chief Operations Officer C/O CARTESIAN THERAPEUTICS, INC., 7495 NEW HORIZON WAY, FREDERICK /s/ Matthew Bartholomae, Attorney-in-Fact for Emily English 02 Jan 2026 0002019791

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNAC Common Stock Options Exercise $24,750 +7,500 +12% $3.30 70,226 30 Dec 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RNAC Stock Option (Right to Buy) Options Exercise -7,500 -28% 19,369 30 Dec 2025 Common Stock 7,500 $3.30 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options are currently fully vested and exercisable.
F2 On November 13, 2023, the issuer acquired the Delaware corporation which was then-known as Cartesian Therapeutics, Inc. ("Old Cartesian") in accordance with the terms of an Agreement and Plan of Merger, dated November 13, 2023. Options to purchase Old Cartesian common stock held by the reporting person were converted into options to purchase shares of the issuer's common stock in connection with the merger.